Accelerator a3600 Automation System using the Aliquoter Module (Inpeco P/N FLX-212) - Product Usa...

FDA Device Recall #Z-2199-2020 — Class II — April 7, 2020

Recall Summary

Recall Number Z-2199-2020
Classification Class II — Moderate risk
Date Initiated April 7, 2020
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Inpeco S.A.
Location Lugano, N/A
Product Type Devices
Quantity 97 systems

Product Description

Accelerator a3600 Automation System using the Aliquoter Module (Inpeco P/N FLX-212) - Product Usage: The systems consolidate multiple Analytical instruments into a unified workstation.

Reason for Recall

In certain firmware versions, in case a Clot Detection error (error code E0E0 or 13E0) is generated during the sample aspiration the current error recovery procedure dispenses 2/3 of sample volume back into the Primary Tube. Evidence from the field showed that in case of Clot Detection error, this management may lead to the dilution of the Primary Tube with the distilled water of the hydraulic circuit of the Aliquoter Module.

Distribution Pattern

US Nationwide distribution including in the states of IL, NY.

Lot / Code Information

Serial Numbers: ACP.002 ACP.004 ACP.009 ACP.011 ACP.012 ACP.015 ACP.018 ACP.019 ACP.026 ACP.027 ACP.028 ACP.033 ACP.034 ACP.042 ACP.045 ACP.047 ACP.048 ACP.050 ACP.052 ACP.059 ACP.061 ACP.063 ACP.064 ACP.066 ACP.069 ACP.070 ACP.071 ACP.073 ACP.076 ACP.085 ACP.088 ACP.092 ACP.093 ACP.101 ACP.102 ACP.104 ACP.113 ACP.119 ACP.120 ACP.123 ACP.131 ACP.141 ACP.142 ACP.146 ACP.163 ACP.164 ACP.171 ACP.172 ACP.182 ACP.185 ACP.186 ACP.194 ACP.205 ACP.209 ACP.214 ACP.217 ACP.218 ACP.226 ACP.229 ACP.230 ACP.232 ACP.233 ACP.235 ACP.236 ACP.237 ACP.242 ACP.243 ACP.244 ACP.248 ACP.250 ACP.252 ACP.253 ACP.257 ACP.258 ACP.259 ACP.263 ACP.265 ACP.267 ACP.268 ACP.275 ACP.276 ACP.280 ACP.286 ACP.289 ACP.290 ACP.291 ACP.294 ACP.295 ACP.297 ACP.298 ACP.299 ACP.303 ACP.304 ACP.314 ACP.323 ACP.332 ACP.336

Other Recalls from Inpeco S.A.

Recall # Classification Product Date
Z-0596-2026 Class II FlexLab (FLX); Version: FLX-217-40; Oct 30, 2025
Z-0595-2026 Class II FlexLab (FLX); Version: FLX-217-10; Oct 30, 2025
Z-0106-2026 Class II FlexLab (FLX) System. Potassium Test System. in... Sep 3, 2025
Z-0107-2026 Class II FlexLab X (FXX) System. Potassium Test System. ... Sep 3, 2025
Z-0560-2024 Class II Roche Cobas 8000 and Cobas PRO Interface Module... Nov 3, 2023

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.